BHCM
ZOM

Brevan Howard Capital Management’s Zomedica Corp. ZOM Stock Holding History

Brevan Howard Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,908
Closed -$2.77K – 1510
2024
Q2 		$2.77K Buy
+18,908
New +$2.83K ﹤0.01% 1018

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Brevan Howard Capital Management's ZOM Position: Q3 2024 in Review

Brevan Howard Capital Management sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 18,908 shares — an estimated $2.77K sold.

Brevan Howard Capital Management first reported a position in ZOM in Q2 2024 and held it in 1 quarter. The position peaked at $2.77K in Q2 2024. 84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • Brevan Howard Capital Management reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 18,908 Zomedica Corp. shares in Q3 2024, an estimated $2.77K.
  • Brevan Howard Capital Management first reported a position in Zomedica Corp. in Q2 2024 and held it in 1 quarter.
  • Brevan Howard Capital Management's Zomedica Corp. position peaked at $2.77K in Q2 2024.
  • 84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.